Ionis Pharmaceuticals Inc (NASDAQ:IONS)
| 47.15 BATS BZX Real-Time Price As of 3:57pm ET |  +0.87 / +1.88%Today’s Change | 32.69 Today|||52-Week Range 47.74 | +24.83% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Major | MARKET CAP $6.1B |
Company Description
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core segment. The Ionis Core segment exploits a novel drug discovery platform to generate a pipeline of drugs. The company was founded by Stanley T. Crooke, David J. Ecker, Christopher K. Mirabelli, and Brett P. Monia on January 10, 1989 and is headquartered in Carlsbad, CA.
Contact Information
Ionis Pharmaceuticals, Inc. 2855 Gazelle Court Carlsbad California 92010 |
Employees
Shareholders
| Mutual fund holders | 59.17% |
| Other institutional | 35.79% |
| Individual stakeholders | 1.13% |
Top Executives
| Brett P. Monia | Chief Executive Officer & Director |
| Onaiza Cadoret-Manier | EVP, Chief Product Strategy & Operations Officer |
| Elizabeth L. Hougen | Chief Financial Officer & Executive VP-Finance |
| C. Frank Bennett | Chief Scientific Officer & Executive VP |
| Sanjay Bhanot | Chief Medical Officer & SVP |
